Exposure to estrogens is associated with an increase in cancers, including malignancies of the breast and uterus in humans, and of the kidney in hamsters. DNA damage induced by metabolic activation of estrogen has been postulated to result in gene mutations critical for the development of estrogen-induced kidney tumors in hamsters. As part of our examination of the genetic consequences of estrogen-induced DNA damage, we searched for estrogen-induced alterations in microsatellite DNA, a frequent site of mutation in tumors. Genomic DNA isolated from kidney of hamsters treated with estradiol, from estrogen-induced kidney tumors and from untreated agematched controls, was examined by Southern blot analysis with three multi-locus oligonucleotide probes: (GACA) 4 , (CAC) 6 and (CAG) 6 . Alterations in DNA fragments containing GACA and CAC tandem repeats were detected in kidney DNA of hamsters treated with hormone for 3 and 4 months, whereas no such effects were seen in control animals. In estrogen-induced tumors, microsatellite alterations were observed in fragments that contain these same two repeat sequences and also CAG repeat sequences. The induction of microsatellite alterations by estradiol in kidney DNA preceding estrogen-induced renal malignancy may play a role in hormone-induced tumorigenesis.
Introduction
The induction of tumors by estrogen in kidneys of male Syrian hamsters (1) has been studied to understand the mechanism of hormone-induced carcinogenesis. Estrogen-induced DNA damage, such as single strand breaks, 8-hydroxylation of guanine bases and other estrogen-induced endogenous DNA adducts, has been detected in vitro and in hamster kidney DNA prior to the development of malignancies (2) (3) (4) (5) (6) . Also, estrogen-induced aneuploidy has been observed in cultured Syrian hamster embryo cells (7) and in kidneys of hamsters treated with estradiol (8) . Such genetic modifications have been postulated to arise from reactive intermediates formed by metabolic activation of estrogens and to be necessary for tumor development (9, 10) . However, despite the ability of estrogens to induce these types of DNA damage and cancer, these hormones have not been considered mutagenic (11) because they failed to induce mutations in classical bacterial or mammalian gene mutation assays (12) (13) (14) . These classical assays were designed to uncover point mutations at specific gene loci and could not have detected other types of mutations, such as chromosomal rearrangements, insertions, deletions, or any type of mutations in any other loci or any non-coding regions where most known microsatellite DNA repeat sequences occur.
Microsatellite instability has been shown to be responsible for or correlate strongly with certain hereditary diseases and a number of malignancies (15) (16) (17) (18) (19) . For instance, mutations identified in vaginal and cervical cancers in 100% of patients exposed to diethylstilbestrol in utero (20) demonstrate the ability of this synthetic estrogen to induce microsatellite DNA alterations in humans. Therefore, in this study we examined DNA from kidney of hamsters treated with estradiol for 3, 4 and 6 months and from kidney tumors for multiple types of alterations occurring in microsatellite DNA. Age-matched untreated hamsters served as controls. Specifically, we searched by Southern blot analysis for mutations by studying restriction fragment lengths of DNA containing tandem repeats of CAG, GACA and CAC. The investigated repeats used in this study have a comparatively low mutation rate, show somatic stability with human DNA (21, 22) and develop no new additional bands due to degradation of DNA (23) . The multi-locus probe methodology chosen for this study allows a genome-wide survey of all microsatellite DNA as opposed to studies using the single-locus PCR-based microsatellite instability assays (17) (18) (19) 24) . The information detected by single-locus human PCR probes is restricted to one locus in the entire genome. Any type of alteration not specifically determined by the PCR primers will thus escape detection. In contrast, the multilocus probes used in this study overcome this limitation by simultaneous monitoring of all altered loci and were thus chosen to detect gross genomic alterations in microsatellitecontaining DNA, which possibly indicate loss of heterozygosity, chromosomal translocations, deletions and insertions that would ordinarily be missed by single-locus probes.
Materials and methods

Chemicals
Chemicals were purchased from the following sources: [γ-32 P]dATP (6000 Ci/mmol) from Amersham (Arlington Heights, IL); agarose and molecular weight markers from Bio-Rad (Richmond, CA); oligonucleotides from Gibco BRL Life Technologies (Grand Island, NY); restriction and modifying enzymes from Boehringer Mannheim (Indianapolis, IN) and Promega (Madison, WI); all other chemicals, reagent grade or better, were from Sigma (St Louis, MO).
Animal treatment
Four-to six-week-old male Syrian hamsters from SASCO (Houston, TX) received one s.c. implant (25 mg estradiol pellet containing 10% cholesterol) initially, and an additional implant 3 months later, as described by Kirkman (1). Animals were killed by decapitation. Whole kidney tissue was stored at -80°C. Tumors occurred in animals treated with E 2 for 6 months, but could not be detected in hamsters treated for 3 and 4 months, which is in line with previous reports (25) .
DNA purification
Tumors separated from surrounding kidney, or kidney sections, were rinsed in phosphate-buffered saline. Genomic DNA was isolated with the Quick Clean DNA Extraction System (Oncogene Science, Uniondale, NY). Briefly, tissue was homogenized, digested with proteinase K and RNase and treated with salt to precipitate proteins. DNA was precipitated with ethanol and resuspended in 50 mM Tris, 0.5 mM EDTA, pH 7.4 Southern analysis A modified Southern blot analysis was performed as previously described (26) . Briefly, 10 µg DNA was digested with 10 U of the indicated restriction enzyme as described by the manufacturer and subjected to 0.8% agarose gel electrophoresis. Gels were dried, hybridized with indicated probes and autoradiographed. Oligonucleotide probes were labeled with [γ-32 P]dATP using T4 kinase and purified by Sephadex G25 column chromatography purchased from Worthington Biochemical (Freehold, NJ).
Results
Renal tumors
Estrogen-induced kidney tumors were observed after 6 months, but could not be detected after 3 and 4 months of exposure of hamsters to this hormone, which is consistent with previous reports (1, 25) . Alterations in restriction fragments containing microsatellite repeats were detected by Southern blot analysis of tumor DNA probed with (GACA) 4 , (CAG) 6 and (CAC) 6 oligonucleotides, which were compared with kidney DNA of age-matched controls. For instance, HaeIII digests of tumors from six different animals that were probed for CAC repeats contained differences in electrophoretic mobility patterns compared with kidney (Figure 1) , which is indicative of estrogeninduced alterations in restriction fragments containing microsatellite repeats. A 16 kb band was lost in the fourth tumor (T) lane and a 7 kb band was gained in the fifth and sixth tumor (T) lanes. The incidence of alterations in DNA from seven different tumors digested with three different restriction enzymes (Sau3AI, HinfI and HaeIII) was determined using the three oligonucleotide probes (GACA) 4 , (CAG) 6 and (CAC) 6 . Alterations were detected in all experiments with the banding patterns for particular restriction enzymes varying from 2/7 to 4/7 tumors studied (Table I) . Normal kidney DNA did not contain this variability (Table I) . Pre-malignant kidney Because mutations could be the result of and not a precursor to tumor formation, we examined kidney DNA from estrogentreated animals prior to the appearance of tumors. Tumors were not detected in hamsters treated for 3 and 4 months, because the earliest kidney tumors occur after 5 months of estrogen treatment (25) . Thus, kidney DNA from hamsters treated with estradiol for 3 or 4 months was analyzed for estrogen-induced mutations prior to tumor development. Alterations in restriction fragments containing microsatellite repeats were detected by Southern blot analysis of tumor DNA Southern analyses with the indicated oligonucleotides of DNA digested with the indicated restriction enzymes were carried out as described in Materials and methods. Each ratio represents the number of samples with a change in the electrophoretic mobility pattern/no. of tissues examined with this specific probe.
probed with (GACA) 4 and (CAC) 6 oligonucleotides compared with kidney DNA of age-matched controls (Table II) . For instance, Sau3AI and HinfI digests of DNA from hamsters treated for 3 and 4 months contained differences in electrophoretic mobility patterns when probed with (GACA) 4 oligonucleotides ( Figure 2) . A new band appeared in both the Sau3AI (15 kb) and the HinfI (8.5 kb) digests of kidney DNA from animals treated for 3 and 4 months with estradiol. No mutations were observed in CAG repeats in these pre-malignant kidneys.
Discussion
In our study, changes have been identified in the size of DNA restriction fragments containing long tandem repeats in kidney of estrogen-treated hamsters and in resultant kidney tumors. Specifically, alterations have been detected in renal tumor DNA fragments containing the tetranucleotide repeat GACA and the two trinucleotide repeats, CAG and CAC. Probing seven different estrogen-induced tumors with each of these oligonucleotides revealed alterations in fragments obtained by three separate restriction enzymes. Analogous alterations in CAG trinucleotide repeat sequences have been previously observed in human soft tissue sarcomas and in cancers of the prostate, brain, ovary and breast (24) . In the same seven tumors, alterations were also observed with the CAC probe in five different restriction fragments. These data demonstrate that estrogen-induced renal hamster tumors contain alterations in DNA fragments containing CAC repeats, similar to those observed in various human cancers (24) . In order to evaluate the potential of estrogens to induce this type of DNA damage, we also studied kidneys of hamsters treated with estradiol for 3 or 4 months prior to the appearance of malignancies, which develop after 5-6 months of hormone exposure (8, 25) . The alterations in GACA and CAC repeat sequences, induced in kidney by the estrogen treatment, demonstrate the ability of estrogens to induce this type of DNA damage prior to the appearance of tumors.
Use of the multi-locus probe methodology allowed the screening of an entire genome of unknown sequence and the Southern analyses of DNA digested with the indicated restriction enzymes and probed with the indicated oligonucleotides were carried out as described in Materials and methods. Each ratio represents the number of samples with a change in the electrophoretic mobility pattern/no. of kidneys examined with this specific probe.
Fig. 2.
Examples of estrogen-induced alterations in microsatellite DNA of kidney treated with estradiol (E 2 ) for 3 or 4 months. Total genomic DNA was isolated from kidneys of hormone-treated hamsters (E 2 ) and from agematched controls (C), digested with Sau3AI or HinfI as indicated, and subjected to Southern analysis by probing with (GACA) 4 oligonucleotide. In the Sau3AI digest of DNA from the hamster exposed to estrogen for 3 months and in one of the animals exposed for 4 months, an~12 kb band appeared (arrow), which was not present in the controls. In the HinfI digest of DNA from the hamster exposed to estrogen for 3 months and one of the animals exposed for 4 months, an~8 kb band appeared (arrow), which was not present in the controls.
potential to detect gross genomic alterations and loss of heterozygosity, such as chromosomal translocations, deletions and insertions, which are missed by single-locus PCR-based microsatellite instability assays (18, 19, 24) . The loss of a 16 kb band (as shown in Figure 1 , fourth tumor lane) results from a deletion from a fragment containing microsatellite DNA. The loss of this band may represent a translocation to a location with a different number of restriction sites. In this case, any new bands formed by the increase in restriction sites would have been very small and therefore unresolved. The appearance of a new band (as shown in Figure 1 , tumor lanes 5 and 6; and in Figure 2 , in lanes containing DNA of estradiol-treated animals) probably represents the amplification of microsatellite DNA, since no other detectable bands were lost. However, it may also represent a translocation of microsatellite DNA from another locus, if the locus of origin retains sufficient microsatellite DNA in order to produce all original detectable bands. Although our data do not resolve minor size differences or provide information about possible changes in DNA sequence in the polymorphic bands, the very fact that they are observed in Southern blots suggests that they are clonal polymorphisms. Since clonal processes are associated with tumorigenesis, it is likely that these polymorphic bands are associated with phenotypes expressed during tumorigenesis.
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In summary, we identified estradiol-induced microsatellite instability in hamster kidney and in renal tumors resulting from hormone treatment. Our results point to estradiol as a tumor-initiating agent in addition to its function as a growth promoter via estrogen receptor-mediated processes. Genes altered by this event have not yet been identified in the hamster genome but are currently under investigation. These alterations are taken as evidence for the ability of estrogens to induce mutations as a result of damage to DNA. Additional events mediated by estrogen receptors may complete the carcinogenic process.
